{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:37:42Z","timestamp":1768408662489,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01277-x","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:35:15Z","timestamp":1752896115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostate-Specific Membrane Antigen Expression in Colorectal Cancer and Its Potential Implication in Disease Monitoring in Rectal Cancer"],"prefix":"10.1007","volume":"56","author":[{"given":"Eundong","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Kmeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureldien","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifton G.","family":"Fulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusret Bekir","family":"Subasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello P.","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Gracz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xulang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-6278","authenticated-orcid":false,"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"5","key":"1277_CR1","doi-asserted-by":"publisher","first-page":"C975","DOI":"10.1152\/ajpcell.00506.2004","volume":"288","author":"AK Rajasekaran","year":"2005","unstructured":"Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol. 2005;288(5):C975\u201381.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"1277_CR2","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","volume":"82","author":"DG Bostwick","year":"1998","unstructured":"Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer. 1998;82(11):2256\u201361.","journal-title":"Cancer"},{"issue":"17","key":"1277_CR3","first-page":"6357","volume":"9","author":"JS Ross","year":"2003","unstructured":"Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res. 2003;9(17):6357\u201362.","journal-title":"Clin Cancer Res"},{"issue":"1160","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/bjr\/tqae092","volume":"97","author":"M Naik","year":"2024","unstructured":"Naik M, Khan SR, Lewington V, Challapalli A, Eccles A, Barwick TD. Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands. Br J Radiol. 2024;97(1160):1391\u2013404.","journal-title":"Br J Radiol"},{"issue":"9","key":"1277_CR5","first-page":"919","volume":"35","author":"C Van de Wiele","year":"2020","unstructured":"Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, et al. PSMA expression on neovasculature of solid tumors. Histol Histopathol. 2020;35(9):919\u201327.","journal-title":"Histol Histopathol"},{"issue":"1","key":"1277_CR6","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):81\u20135.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1277_CR7","first-page":"2674","volume":"5","author":"SS Chang","year":"1999","unstructured":"Chang SS, O\u2019Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5(10):2674\u201381.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1038\/s41598-017-05481-z","volume":"7","author":"A Bychkov","year":"2017","unstructured":"Bychkov A, Vutrapongwatana U, Tepmongkol S, Keelawat S. PSMA expression by microvasculature of thyroid tumors - potential implications for PSMA theranostics. Sci Rep. 2017;7(1):5202.","journal-title":"Sci Rep"},{"issue":"2","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.juro.2017.08.079","volume":"199","author":"S Spatz","year":"2018","unstructured":"Spatz S, Tolkach Y, Jung K, Stephan C, Busch J, Ralla B, et al. Comprehensive evaluation of prostate specific membrane antigen expression in the vasculature of renal tumors: implications for imaging studies and prognostic role. J Urol. 2018;199(2):370\u20137.","journal-title":"J Urol"},{"issue":"5","key":"1277_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","volume":"10","author":"D Jiao","year":"2019","unstructured":"Jiao D, Li Y, Yang F, Han D, Wu J, Shi S, et al. Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(5):1\u20137.","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"1277_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.prp.2014.05.015","volume":"210","author":"M Abdel-Hadi","year":"2014","unstructured":"Abdel-Hadi M, Ismail Y, Younis L. Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients. Pathol Res Pract. 2014;210(11):759\u201363.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","volume":"40","author":"MC Haffner","year":"2009","unstructured":"Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, M\u00fchlmann G, et al. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol. 2009;40(12):1754\u201361.","journal-title":"Hum Pathol"},{"issue":"5","key":"1277_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00259-017-3922-y","volume":"45","author":"P Backhaus","year":"2018","unstructured":"Backhaus P, Noto B, Avramovic N, Grubert LS, Huss S, B\u00f6gemann M, et al. Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives. Eur J Nucl Med Mol Imaging. 2018;45(5):860\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1277_CR14","doi-asserted-by":"publisher","first-page":"1220586","DOI":"10.3389\/fonc.2023.1220586","volume":"13","author":"JH Wang","year":"2023","unstructured":"Wang JH, Kiess AP. PSMA-targeted therapy for non-prostate cancers. Front Oncol. 2023;13:1220586.","journal-title":"Front Oncol"},{"issue":"7","key":"1277_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/RLU.0000000000003081","volume":"45","author":"A Ar\u00e7ay","year":"2020","unstructured":"Ar\u00e7ay A, Eiber M, Langbein T. Incidental finding of colon carcinoma related to high uptake in 18F-PSMA-1007 PET. Clin Nucl Med. 2020;45(7):561\u20132.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"1277_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/RLU.0000000000001700","volume":"42","author":"L Hangaard","year":"2017","unstructured":"Hangaard L, Jochumsen MR, Vendelbo MH, Bouchelouche K. Metastases from colorectal cancer avid on 68Ga-PSMA PET\/CT. Clin Nucl Med. 2017;42(7):532\u20133.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ctrv.2015.06.007","volume":"41","author":"K Tamas","year":"2015","unstructured":"Tamas K, Walenkamp AM, de Vries EG, van Vugt MA, Beets-Tan RG, van Etten B, et al. Rectal and colon cancer: not just a different anatomic site. Cancer Treat Rev. 2015;41(8):671\u20139.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.acpath.2022.100063","volume":"10","author":"M Kmeid","year":"2023","unstructured":"Kmeid M, Brar R, Sullivan L, Arslan ME, Shrestha N, Lee EC, et al. Diagnostic yield and repeat biopsies in rectal and nonrectal colorectal adenocarcinoma: are we hedging on rectal biopsies? Acad Pathol. 2023;10(1):100063.","journal-title":"Acad Pathol"},{"issue":"10","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(10):1139\u201367.","journal-title":"J Natl Compr Canc Netw."},{"issue":"16","key":"1277_CR20","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926\u201333.","journal-title":"J Clin Oncol"},{"issue":"15","key":"1277_CR21","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1200\/JCO.2011.39.7901","volume":"30","author":"IJ Park","year":"2012","unstructured":"Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012;30(15):1770\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.seminoncol.2020.02.001","volume":"47","author":"B Oronsky","year":"2020","unstructured":"Oronsky B, Reid T, Larson C, Knox SJ. Locally advanced rectal cancer: the past, present, and future. Semin Oncol. 2020;47(1):85\u201392.","journal-title":"Semin Oncol"},{"key":"1277_CR23","doi-asserted-by":"publisher","unstructured":"Smith HG, Nilsson PJ, Shogan BD, Harji D, Gambacorta MA, Romano A,\u00a0Brandl A, Qvortrup C. Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. 2024;8(3):zrae038. https:\/\/doi.org\/10.1093\/bjsopen\/zrae038.","DOI":"10.1093\/bjsopen\/zrae038"},{"issue":"4","key":"1277_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/SLA.0b013e31828f6c91","volume":"259","author":"AM Hanly","year":"2014","unstructured":"Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC. Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy. Ann Surg. 2014;259(4):723\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.surg.2015.10.019","volume":"159","author":"EA de Jong","year":"2016","unstructured":"de Jong EA, ten Berge JC, Dwarkasing RS, Rijkers AP, van Eijck CH. The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: a metaanalysis. Surgery. 2016;159(3):688\u201399.","journal-title":"Surgery"},{"issue":"10","key":"1277_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/codi.13081","volume":"17","author":"JE Ryan","year":"2015","unstructured":"Ryan JE, Warrier SK, Lynch AC, Heriot AG. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis. 2015;17(10):849\u201361.","journal-title":"Colorectal Dis"},{"issue":"6","key":"1277_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.crad.2011.11.004","volume":"67","author":"JM Franklin","year":"2012","unstructured":"Franklin JM, Anderson EM, Gleeson FV. MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Clin Radiol. 2012;67(6):546\u201352.","journal-title":"Clin Radiol"},{"issue":"3","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/DCR.0000000000000743","volume":"60","author":"JJ van den Broek","year":"2017","unstructured":"van den Broek JJ, van der Wolf FS, Lahaye MJ, Heijnen LA, Meischl C, Heitbrink MA, et al. Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum. 2017;60(3):274\u201383.","journal-title":"Dis Colon Rectum"},{"key":"1277_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1748-717X-8-278","volume":"8","author":"R Dickman","year":"2013","unstructured":"Dickman R, Kundel Y, Levy-Drummer R, Purim O, Wasserberg N, Fenig E, et al. Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study. Radiat Oncol. 2013;8:278.","journal-title":"Radiat Oncol"},{"issue":"13","key":"1277_CR30","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1007\/s00259-021-05433-w","volume":"48","author":"MJM Uijen","year":"2021","unstructured":"Uijen MJM, Derks YHW, Merkx RIJ, Schilham MGM, Roosen J, Priv\u00e9 BM, et al. PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports. Eur J Nucl Med Mol Imaging. 2021;48(13):4350\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1277_CR31","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1097\/RLU.0000000000001672","volume":"42","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Schaarschmidt BM, Sawicki LM, Heusch P, Hautzel H, Ermert J, et al. Evaluation of practical interpretation hurdles in 68Ga-PSMA PET\/CT in 55 patients: physiological tracer distribution and incidental tracer uptake. Clin Nucl Med. 2017;42(7):e322\u20137.","journal-title":"Clin Nucl Med"},{"key":"1277_CR32","unstructured":"AJCC. Cancer Staging Manual. 8 ed. New York, Springer Cham; 2017."},{"issue":"5","key":"1277_CR33","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3390\/curroncol29050263","volume":"29","author":"L Sullivan","year":"2022","unstructured":"Sullivan L, Pacheco RR, Kmeid M, Chen A, Lee H. Tumor stroma ratio and its significance in locally advanced colorectal cancer. Curr Oncol. 2022;29(5):3232\u201341.","journal-title":"Curr Oncol"},{"issue":"12","key":"1277_CR34","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/PAS.0000000000001971","volume":"46","author":"M Kmeid","year":"2022","unstructured":"Kmeid M, Park YN, Chung T, Lukose G, Sullivan L, Brar R, et al. PSMA immunohistochemistry in hepatic neoplasms: a promising diagnostic marker with potential theranostic applications. Am J Surg Pathol. 2022;46(12):1688\u201399.","journal-title":"Am J Surg Pathol"},{"key":"1277_CR35","doi-asserted-by":"publisher","first-page":"646387","DOI":"10.3389\/fonc.2021.646387","volume":"11","author":"A Holzgreve","year":"2021","unstructured":"Holzgreve A, Biczok A, Ruf VC, Liesche-Starnecker F, Steiger K, Kirchner MA, et al. PSMA expression in glioblastoma as a basis for theranostic approaches: a retrospective, correlational panel study including immunohistochemistry, clinical parameters and PET imaging. Front Oncol. 2021;11:646387.","journal-title":"Front Oncol"},{"issue":"Suppl 2","key":"1277_CR36","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.21037\/tau.2019.04.10","volume":"8","author":"G Morgantetti","year":"2019","unstructured":"Morgantetti G, Ng KL, Samaratunga H, Rhee H, Gobe GC, Wood ST. Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis. Transl Androl Urol. 2019;8(Suppl 2):S147\u201355.","journal-title":"Transl Androl Urol"},{"key":"1277_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.suronc.2019.06.003","volume":"30","author":"AJ Gelibter","year":"2019","unstructured":"Gelibter AJ, Caponnetto S, Urbano F, Emiliani A, Scagnoli S, Sirgiovanni G, et al. Adjuvant chemotherapy in resected colon cancer: when, how and how long? Surg Oncol. 2019;30:100\u20137.","journal-title":"Surg Oncol"},{"issue":"2","key":"1277_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ags3.12652","volume":"7","author":"H Ueno","year":"2023","unstructured":"Ueno H, Nagtegaal ID, Quirke P, Sugihara K, Ajioka Y. Tumor deposits in colorectal cancer: refining their definition in the TNM system. Ann Gastroenterol Surg. 2023;7(2):225\u201335.","journal-title":"Ann Gastroenterol Surg"},{"key":"1277_CR39","doi-asserted-by":"publisher","first-page":"598377","DOI":"10.3389\/fcell.2021.598377","volume":"9","author":"Y Gao","year":"2021","unstructured":"Gao Y, Zheng H, Li L, Feng M, Chen X, Hao B, et al. Prostate-specific membrane antigen (PSMA) promotes angiogenesis of glioblastoma through interacting with ITGB4 and regulating NF-\u03baB signaling pathway. Front Cell Dev Biol. 2021;9:598377.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"1277_CR40","doi-asserted-by":"publisher","first-page":"e0125924","DOI":"10.1371\/journal.pone.0125924","volume":"10","author":"HL Wang","year":"2015","unstructured":"Wang HL, Wang SS, Song WH, Pan Y, Yu HP, Si TG, et al. Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS ONE. 2015;10(5):e0125924.","journal-title":"PLoS ONE"},{"issue":"10","key":"1277_CR41","doi-asserted-by":"publisher","first-page":"e0186280","DOI":"10.1371\/journal.pone.0186280","volume":"12","author":"LH Schmidt","year":"2017","unstructured":"Schmidt LH, Heitk\u00f6tter B, Schulze AB, Schliemann C, Steinestel K, Trautmann M, et al. Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer. PLoS ONE. 2017;12(10):e0186280.","journal-title":"PLoS ONE"},{"issue":"2","key":"1277_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/01.RES.0000204553.32549.a7","volume":"98","author":"WC Aird","year":"2006","unstructured":"Aird WC. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res. 2006;98(2):159\u201362.","journal-title":"Circ Res"},{"issue":"3","key":"1277_CR43","doi-asserted-by":"publisher","first-page":"a006536","DOI":"10.1101\/cshperspect.a006536","volume":"2","author":"AC Dudley","year":"2012","unstructured":"Dudley AC. Tumor endothelial cells. Cold Spring Harb Perspect Med. 2012;2(3):a006536.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"1277_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00441-008-0672-y","volume":"335","author":"WC Aird","year":"2009","unstructured":"Aird WC. Molecular heterogeneity of tumor endothelium. Cell Tissue Res. 2009;335(1):271\u201381.","journal-title":"Cell Tissue Res"},{"issue":"8","key":"1277_CR45","first-page":"a005090","volume":"3","author":"DR Senger","year":"2011","unstructured":"Senger DR, Davis GE. Angiogenesis Cold Spring Harb Perspect Biol. 2011;3(8):a005090.","journal-title":"Angiogenesis Cold Spring Harb Perspect Biol"},{"issue":"14","key":"1277_CR46","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1128\/MCB.00084-06","volume":"26","author":"RE Conway","year":"2006","unstructured":"Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol. 2006;26(14):5310\u201324.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1277_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1754-9485.13116","volume":"65","author":"N Dhiantravan","year":"2021","unstructured":"Dhiantravan N, Ravi Kumar AS, Cavanagh K, McDowell L. A role of PSMA PET\/CT in multimodality imaging approach in adenoid cystic carcinoma. J Med Imaging Radiat Oncol. 2021;65(2):213\u20135.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"1277_CR48","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/RLU.0000000000003359","volume":"46","author":"P Sakthivel","year":"2021","unstructured":"Sakthivel P, Thakar A, Thankarajan Arunraj S, Bhalla AS, Kumar R. Advantage of 68Ga-PSMA PET\/CT on postradiotherapy response assessment of juvenile nasal angiofibroma. Clin Nucl Med. 2021;46(2):e123\u20134.","journal-title":"Clin Nucl Med"},{"key":"1277_CR49","doi-asserted-by":"publisher","first-page":"782166","DOI":"10.3389\/fonc.2021.782166","volume":"11","author":"E Seront","year":"2021","unstructured":"Seront E, Lhommel R, Tombal B. Case Report: Early (68)Ga-PSMA-PET metabolic assessment and response to systemic treatment for first-line metastatic clear cell renal cell carcinoma; about two clinical cases. Front Oncol. 2021;11:782166.","journal-title":"Front Oncol"},{"issue":"1","key":"1277_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00259-023-06413-y","volume":"51","author":"E Ozkan","year":"2023","unstructured":"Ozkan E, Demir B, Oz DK, Soydal C, Dursun E, Celebioglu EC, et al. Demonstration of therapy response to radioembolization with (90)Y resin microspheres on (68)Ga-PSMA PET\/MRI in a patient with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2023;51(1):316\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1277_CR51","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00259-020-05165-3","volume":"48","author":"LM Mittlmeier","year":"2021","unstructured":"Mittlmeier LM, Unterrainer M, Rodler S, Todica A, Albert NL, Burgard C, et al. (18)F-PSMA-1007 PET\/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. Eur J Nucl Med Mol Imaging. 2021;48(6):2031\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1277_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1754-9485.12590","volume":"61","author":"S Siva","year":"2017","unstructured":"Siva S, Callahan J, Pryor D, Martin J, Lawrentschuk N, Hofman MS. Utility of (68) Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma. J Med Imaging Radiat Oncol. 2017;61(3):372\u20138.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"1277_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13550-021-00756-z","volume":"11","author":"N Aide","year":"2021","unstructured":"Aide N, Poulain L, Elie N, Briand M, Giffard F, Blanc-Fournier C, et al. A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers. EJNMMI Res. 2021;11(1):11.","journal-title":"EJNMMI Res"},{"key":"1277_CR54","doi-asserted-by":"crossref","unstructured":"Vuijk FA, Kleiburg F, Noortman WA, Heijmen L, Feshtali Shahbazi S, van Velden FHP, et al. Prostate-specific membrane antigen targeted Pet\/CT imaging in patients with colon, gastric and pancreatic cancer. Cancers (Basel) 2022;14(24)","DOI":"10.3390\/cancers14246209"},{"issue":"7","key":"1277_CR55","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2967\/jnumed.117.204669","volume":"59","author":"FL Giesel","year":"2018","unstructured":"Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, et al. Intraindividual comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET\/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study. J Nucl Med. 2018;59(7):1076\u201380.","journal-title":"J Nucl Med"},{"issue":"3","key":"1277_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10456-024-09913-z","volume":"27","author":"F Yang","year":"2024","unstructured":"Yang F, Lee G, Fan Y. Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism. Angiogenesis. 2024;27(3):333\u201349.","journal-title":"Angiogenesis"},{"issue":"7","key":"1277_CR57","doi-asserted-by":"publisher","first-page":"e41285","DOI":"10.1371\/journal.pone.0041285","volume":"7","author":"CL Grant","year":"2012","unstructured":"Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, et al. Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. PLoS ONE. 2012;7(7):e41285.","journal-title":"PLoS ONE"},{"issue":"4","key":"1277_CR58","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larriv\u00e9e B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409\u201326.","journal-title":"Angiogenesis"},{"issue":"1","key":"1277_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00411-013-0497-2","volume":"53","author":"M Orth","year":"2014","unstructured":"Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maih\u00f6fer C, et al. Current concepts in clinical radiation oncology. Radiat Environ Biophys. 2014;53(1):1\u201329.","journal-title":"Radiat Environ Biophys"},{"key":"1277_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","volume":"16","author":"RK Jain","year":"2014","unstructured":"Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng. 2014;16:321\u201346.","journal-title":"Annu Rev Biomed Eng"},{"key":"1277_CR61","doi-asserted-by":"publisher","first-page":"980058","DOI":"10.3389\/fonc.2022.980058","volume":"12","author":"P Truckenmueller","year":"2022","unstructured":"Truckenmueller P, Graef J, Scheel M, Vajkoczy P, Capper D, Kaul D, et al. [(68)Ga]Ga-PSMA PET\/MRI, histological PSMA expression and preliminary experience with [(177)Lu]Lu-PSMA therapy in relapsing high-grade glioma. Front Oncol. 2022;12:980058.","journal-title":"Front Oncol"},{"issue":"3","key":"1277_CR62","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11060-018-2825-5","volume":"138","author":"M Matsuda","year":"2018","unstructured":"Matsuda M, Ishikawa E, Yamamoto T, Hatano K, Joraku A, Iizumi Y, et al. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with (89)Zr-Df-IAB2M anti-PSMA minibody. J Neurooncol. 2018;138(3):581\u20139.","journal-title":"J Neurooncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01277-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:37:19Z","timestamp":1757259439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01277-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01277-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"5 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board at Albany Medical College (protocol #5718, approval date 06\/19\/2020) and Cleveland Clinic Foundation (IRB #23\u2013225, approval date 03\/02\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No material from other sources was used in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to Reproduce Material from Other Sources"}}],"article-number":"159"}}